Le Lézard
Classified in: Health
Subject: MRR

Global Oral Dosage Forms Market Outlook Report 2021-2026: Competitive Positioning from Industry Familiarity, Usage, and Preference Rates Among a Set of 49 Leading CMOs


DUBLIN, Oct. 22, 2021 /PRNewswire/ -- The "Oral Dosage Forms Market Outlook (4th Ed.)" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This report provides an overview of the current market dynamics in the oral dose contract manufacturing space as well as an outlook of what the survey respondents - all oral dose outsourcing decision-makers at sponsor organizations - predict the marketplace will look like in 2026.

Oral dosage forms have a long history and enjoy market dominance, making this category of drug product a strong candidate for outsourced manufacturing, including to CMOs in emerging markets.

Key statistics include oral dose project volume, percentage outsourced, and the average number of CMOs used to complete the work; an analysis of 17 different oral dosage forms which includes utilization rates, the percentage of marketed oral dose products for each form, the proportion of manufacturing that is outsourced by form, and a breakdown of outsourcing expenditure by form as well as which oral dosage forms will grow in use over the next five years and which may lose market share.

Additionally, outsourcers will share insights on what works and what hasn't worked when partnering with CMOs for oral drug product manufacturing.

What You Will Learn:

Drug Developers:

Contract Manufacturers:

Major Topics:

Key Topics Covered:

1. Introduction

2. Methodology

3. Respondent Demographics

4. Major Sections

5. Market Dynamics

6. Service Provider Selection Attributes

7. Trends, Predictions, and Preferences

8. Geographic Preferences

9. Study Data

10. Demographics

For more information about this report visit https://www.researchandmarkets.com/r/17wrcn

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 21:00
Nikon Instruments Inc., innovator of advanced microscope systems today announced the release of the AX R MP multiphoton confocal microscope, which can acquire high resolution, large field of view images, deep within living organisms at high speed....

at 20:56
A group of six pharmacy organizations today criticized the decision of the U.S. Centers for Medicare & Medicaid Services (CMS) to only "encourage" but not require payment to pharmacists for testing, patient assessment, ordering/prescribing and...

at 20:00
Helix BioPharma Corp. ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is providing this bi-weekly update on the status of the management...

at 19:55
Ahead of the oral arguments in Dobbs v. Jackson Women's Health Center, the first direct challenge to Roe v. Wade in a generation, Family Research Council published a new comprehensive issue brief identifying the United States as one of only six...

at 19:25
This Giving Tuesday and World AIDS Day, (RED), the organization co-founded by Bono and Bobby Shriver, is marking its 15th anniversary year by offering a number of exciting ways to support the fight against AIDS and COVID-19. (RED) partners and...

at 19:15
Aditxt, Inc. ("Aditxt") , a biotech innovation company with a mission to improve the health of the immune system, announced today the launch of an underwritten public offering. Dawson James Securities, Inc. is acting as sole book-running manager for...



News published on 22 october 2021 at 13:00 and distributed by: